New muscle relaxant drug MTR-601 tested in humans for first time
Symptom relief
Completed
This early-stage trial tested a new oral drug called MTR-601 in 89 healthy adults to see if it is safe and how the body processes it. The drug aims to reduce muscle stiffness and spasms, which could help people with conditions like cerebral palsy, multiple sclerosis, or stroke. S…
Phase: PHASE1 • Sponsor: Motric Bio • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC